DL-Glutamic acid monohydrate

We are DL-Glutamic acid monohydrate CAS:19285-83-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 19285-83-7
Product Name: DL-Glutamic acid monohydrate
Other Name:
DL-Glutamic acid monohydrate
H-DL-Glu-OH·H2O
DL-Glu hydrate
DL-2-Aminopentanedioic acid
Glutamic acid hydrate (1:1)
2-Aminopentanedioic acid hydrate
Dl-Glutamic Acid Hydrate
H-DL-Glu-OH·H2O
 
Density: 1.4601
Boiling Point: 430.7ºC at 760mmHg
Melting Point: 194 °C
Molecular Formula: C5H11NO5
Molecular Weight: 165.145
Flash Point: 214.3ºC
Exact Mass: 165.063721
PSA: 109.85000
Vapour Pressure: 8.01E-09mmHg at 25°C
Storage condition: Store at RT.
Water Solubility: 20.54 g/L (25 ºC)
 
Specification
Appearance: White powder
Assay: ≥98.0%
Chloride: ≤0.10%
Heavy metal: ≤10ppm
Arsenic: ≤2ppm
Residue on ignition : ≤0.20%
Loss on drying: ≤0.50%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

DL-Glutamic acid monohydrate


Related News: According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).9'-fenil-9H, 9'H-2,3'-bicarbazol CAS:1345202-03-0 f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national.1,4-Naphthalenedione The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.Etil (1S, 5R, 6S) -5- (pentan-3-il-oxi) -7-oxa-biciclo [4.1.0] hept-3-eno-3-carboxilato CAS:204254-96-6 The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.Massachusetts state health officials, in conjunction with Massport, local health departments, and other medical partners, have responded to prevent the spread of the virus.

Related Products
Product Name
dimethyl sulfate View Details
manganese acetate tetrahydrate Cas:6156-78-1 View Details
Vanillyl butyl ether Cas:82654-98-6 View Details
ethyl 2-[(5-tert-butyl-1H-1,2,4-triazol-3-yl)sulfanyl]acetate manufacturer glycidyl neodecanoate Cas:26761-45-5 manufacturer QUININE SULFATE Cas:804-63-7 manufacturer (e,e)-10,12-hexadecadien-1-ol Cas:765-19-5 manufacturer 4-Methyl-N3-[4-(3-Pyridinyl)-2-Pyrimidinyl]-1,3-Benzenediamine manufacturer